Optical Coherence Tomography in Neurologic Diseases

Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account

Peter A. Calabresi is Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmunology and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Laura J. Balcer is Professor and Vice Chair, Department of Neurology, New York University Langone Medical Center, New York, USA. Elliot M. Frohman is a Professor of Neurology, Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.